Abstract:Autism spectrum disorders (ASDs) are perhaps the most severe, intractable and challenging child psychiatric disorders. They are complex, pervasive and highly heterogeneous and depend on multifactorial neurodevelopmental conditions. Although the pathogenesis of autism remains unclear, it revolves around altered neurodevelopmental patterns and their implications for brain function, although these cannot be specifically linked to symptoms. While these affect neuronal migration and connectivity, little is known about the processes that lead to the disruption of specific laminar excitatory and inhibitory cortical circuits, a key feature of ASD. It is evident that ASD has multiple underlying causes and this multigenic condition has been considered to also dependent on epigenetic effects, although the exact nature of the factors that could be involved remains unclear. However, besides the possibility for differential epigenetic markings directly affecting the relative expression levels of individual genes or groups of genes, there are at least three mRNA epitranscriptomic mechanisms, which function cooperatively and could, in association with both genotypes and environmental conditions, alter spatiotemporal proteins expression patterns during brain development, at both quantitative and qualitative levels, in a tissue-specific, and context-dependent manner. As we have already postulated, sudden changes in environmental conditions, such as those conferred by maternal inflammation/immune activation, influence RNA epitranscriptomic mechanisms, with the combination of these processes altering fetal brain development. Herein, we explore the postulate whereby, in ASD pathogenesis, RNA epitranscriptomics might take precedence over epigenetic modifications. RNA epitranscriptomics affects real-time differential expression of receptor and channel proteins isoforms, playing a prominent role in central nervous system (CNS) development and functions, but also RNAi which, in turn, impact the spatiotemporal expression of receptors, channels and regulatory proteins irrespective of isoforms. Slight dysregulations in few early components of brain development, could, depending upon their extent, snowball into a huge variety of pathological cerebral alterations a few years after birth. This may very well explain the enormous genetic, neuropathological and symptomatic heterogeneities that are systematically associated with ASD and psychiatric disorders at large.

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Dopaminergic Signaling is Linked to Neurodevelopmental Deficits in Autism Spectrum Disorder (ASD)

[Research Advances in the Role of Mtor Signaling Pathway in Autism Spectrum Disorder].

Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

The neurodevelopmental role of dopaminergic signaling in neurological disorders

Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development

Dopamine Dysregulation in Reward and Autism Spectrum Disorder

Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy

Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders

A novel mutation in intron 1 of Wnt1 causes developmental loss of dopaminergic neurons in midbrain and ASD-like behaviors in rats

High-throughput functional analysis of autism genes in zebrafish identifies convergence in dopaminergic and neuroimmune pathways

Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment

RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis

Dynamic Functional Connectivity Alterations and Their Associated Gene Expression Pattern in Autism Spectrum Disorders

Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice

Progress towards understanding risk factor mechanisms in the development of autism spectrum disorders

variants cause autism spectrum disorder the downregulation of WNT/β-catenin signaling pathway

Disruption of an Evolutionarily Novel Synaptic Expression Pattern in Autism

Autism spectrum disorders: autistic phenotypes and complicated mechanisms

Synaptopathology Involved in Autism Spectrum Disorder

Diencephalic and Neuropeptidergic Dysfunction in Zebrafish with Autism Risk Mutations